Ginkgo Bioworks Holdings Inc (DNA)
0.8404
0.00 (0.00%)
USD |
NYSE |
May 02, 12:12
Ginkgo Bioworks Holdings Profit Margin (Quarterly): -609.1% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -609.1% |
| September 30, 2023 | -546.4% |
| June 30, 2023 | -215.1% |
| March 31, 2023 | -254.0% |
| December 31, 2022 | -178.5% |
| September 30, 2022 | -1.01K% |
| June 30, 2022 | -462.5% |
| Date | Value |
|---|---|
| March 31, 2022 | -350.6% |
| December 31, 2021 | -1.08K% |
| September 30, 2021 | -131.3% |
| June 30, 2021 | -123.6% |
| March 31, 2021 | -166.8% |
| December 31, 2020 | -146.4% |
| September 30, 2020 | -195.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.08K%
Minimum
Dec 2021
-123.6%
Maximum
Jun 2021
-390.5%
Average
-234.5%
Median
Profit Margin (Quarterly) Benchmarks
| Agenus Inc | -55.24% |
| Teladoc Health Inc | -12.67% |
| Sarepta Therapeutics Inc | 11.51% |
| Ultragenyx Pharmaceutical Inc | -96.70% |
| Apellis Pharmaceuticals Inc | -60.51% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -62.03% |
| Return on Assets | -40.81% |
| Return on Invested Capital | -62.03% |
| Gross Profit Margin (Quarterly) | 80.98% |
| Operating Margin (Quarterly) | -512.5% |
| Return on Net Operating Assets | -105.3% |